Coherus Oncology, Inc.CHRSNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank54
3Y CAGR-20.8%
5Y CAGR-6.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-20.8%/yr
vs +20.5%/yr prior
5Y CAGR
-6.7%/yr
Recent deceleration
Acceleration
-41.3pp
Decelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $98.50M | -34.5% |
| 2024 | $150.44M | -19.0% |
| 2023 | $185.62M | -6.5% |
| 2022 | $198.48M | +17.0% |
| 2021 | $169.71M | +22.0% |
| 2020 | $139.08M | +1.5% |
| 2019 | $137.04M | +45.5% |
| 2018 | $94.18M | +32.1% |
| 2017 | $71.30M | +38.2% |
| 2016 | $51.60M | - |